is metformin a glp 1 New aspects of an old drug: as glucagon-like peptide (GLP-1) enhancer and sensitiser | Diabetologia Synergistic effects of metformin with

Mechanism of Action Inhibits Nicotinamide N-Methyltransferase (NNMT) Increases intracellular nicotinamide and NAD levels Improves mitochondrial efficiency and energy metabolism Supports lipolysis and fat oxidation Reduces adipocyte (fat cell) growth and proliferation Modulates inflammatory pathways and insulin signaling These effects may lead to enhanced fat metabolism, better blood sugar regulation, improved endurance, and a general increase in metabolic flexibility

When a new prescription drug enters the market, the question for employers isnt just does it work? Its what does covering it mean for our people, our plan, and our longterm costs? That question became especially relevant in early 2026, when an oral version of Wegovy entered the market with widespread media coverage

INR/PT Elevated PT has a strong predictive value for the development of hepatotoxicity

Glutamine plays an important role in regulating the immune response and reducing inflammation in the gastrointestinal (GI) tract